Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × Calcium × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Disease Progression 1

Interventions

Lenalidomide 4 Dexamethasone 4 Bortezomib 3 pomalidomide 2 Cyclophosphamide 2 ricolinostat 1 Zoledronic Acid 1 Vitamin D 1 Transplantation, Autologous 1 Melphalan 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Calcium Dobesilate 1 Calcium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated

143 enrolled 10 charts

Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡